# Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

> **NCT00003617** · PHASE3 · UNKNOWN · sponsor: **Lymphoma Trials Office** · enrollment: 200 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** chlorambucil
- **DRUG:** clarithromycin
- **DRUG:** omeprazole
- **DRUG:** tinidazole

## Key facts

- **NCT ID:** NCT00003617
- **Lead sponsor:** Lymphoma Trials Office
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1995-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003617, "Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00003617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*